Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 25Recruiting 5Unknown 4Terminated 3Active not recruiting 3Withdrawn 1Suspended 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Breast Neoplasms 723Neoplasms 461Prostatic Neoplasms 398Carcinoma, Non-Small-Cell Lung 388Lung Neoplasms 311Leukemia, Myeloid, Acute 301Multiple Myeloma 270Colorectal Neoplasms 243Neoplasm Metastasis 240Pancreatic Neoplasms 238Leukemia 235Melanoma 217Lymphoma 213Precursor Cell Lymphoblastic Leukemia-Lymphoma 204Brain Neoplasms 195Recurrence 178Head and Neck Neoplasms 177Lymphoma, Non-Hodgkin 174Myelodysplastic Syndromes 168Leukemia, Lymphocytic, Chronic, B-Cell 168Ovarian Neoplasms 160Carcinoma, Hepatocellular 154Glioblastoma 149Carcinoma, Renal Cell 137Rectal Neoplasms 134Colonic Neoplasms 129Lymphoma, Large B-Cell, Diffuse 125Lymphoma, Follicular 125Hodgkin Disease 116Squamous Cell Carcinoma of Head and Neck 109

Interventions

Resistance Training 1Mirtazapine 1Metformin 1Exercise 1Diet Therapy 1Caloric Restriction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × OTHER × Body Weight × Clear all
NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

NCT01775176 2021-08-24

PULSE-A

Pennington Biomedical Research Center

Terminated
17 enrolled

Body Weight, Insulin Resistance, Polycystic Ovary Syndrome

NCT00832520 2018-04-10

Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight

New Mexico Cancer Research Alliance

Phase 2 Terminated
13 enrolled 4 charts

Body Weight, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡